* PROCEPT BioRobotics Corp PRCT.OQ reported a quarterly
adjusted
loss of 56 cents per share for the quarter ended in December.
The mean expectation of seven analysts for the quarter was for a
loss of 54 cents per share.
* Revenue rose 134.5% to $23.78 million from a year ago;
analysts
expected $23.01 million.
* PROCEPT BioRobotics Corp's reported EPS for the quarter
was a
loss of 63 cents.
* The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* PROCEPT BioRobotics Corp shares had fallen by 10.1% this
quarter.
* The company reported a quarterly loss of $28.17 million.
* Wall Street's median 12-month price target for PROCEPT
BioRobotics Corp is $52.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
28 at 10:55 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.54 -0.56 Missed
Sep. 30 2022 -0.48 -0.51 Missed
Jun. 30 2022 -0.48 -0.43 Beat
Mar. 31 2022 -0.47 -0.39 Beat